303 related articles for article (PubMed ID: 29760745)
1. Diagnostic value of decoy receptor 3 combined with procalcitonin and soluble urokinase-type plasminogen activator receptor for sepsis.
Zhao JJ; Lou XL; Chen HW; Zhu FT; Hou YQ
Cell Mol Biol Lett; 2018; 23():22. PubMed ID: 29760745
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of soluble urokinase plasminogen activator receptor (suPAR) for prediction of bacteremia in patients with systemic inflammatory response syndrome.
Hoenigl M; Raggam RB; Wagner J; Valentin T; Leitner E; Seeber K; Zollner-Schwetz I; Krammer W; Prüller F; Grisold AJ; Krause R
Clin Biochem; 2013 Feb; 46(3):225-9. PubMed ID: 23159293
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic value of soluble urokinase plasminogen activator receptor (suPAR) compared to C-reactive protein (CRP) and procalcitonin (PCT) in children with systemic inflammatory response syndrome (SIRS).
Şirinoğlu M; Soysal A; Karaaslan A; Kepenekli Kadayifci E; Yalındağ-Öztürk N; Cinel İ; Yaman A; Haklar G; Şirikci Ö; Turan S; Altınkanat Gelmez G; Söyletir G; Bakır M
J Infect Chemother; 2017 Jan; 23(1):17-22. PubMed ID: 27771157
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of soluble urokinase-type plasminogen activator receptor in the diagnosis, prognosis, and therapeutic guidance of sepsis.
Zeng M; Chang M; Zheng H; Li B; Chen Y; He W; Huang C
Am J Emerg Med; 2016 Mar; 34(3):375-80. PubMed ID: 26615223
[TBL] [Abstract][Full Text] [Related]
5. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study.
Kofoed K; Andersen O; Kronborg G; Tvede M; Petersen J; Eugen-Olsen J; Larsen K
Crit Care; 2007; 11(2):R38. PubMed ID: 17362525
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of a combination of biomarkers in patients with sepsis and severe sepsis in emergency department].
Zhao Y; Li C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):153-8. PubMed ID: 24598287
[TBL] [Abstract][Full Text] [Related]
7. Soluble urokinase-type plasminogen activator receptor in patients with suspected infection in the emergency room: a prospective cohort study.
Uusitalo-Seppälä R; Huttunen R; Tarkka M; Aittoniemi J; Koskinen P; Leino A; Vahlberg T; Rintala EM
J Intern Med; 2012 Sep; 272(3):247-56. PubMed ID: 22755554
[TBL] [Abstract][Full Text] [Related]
8. [Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac operation].
Dong Z; Jianxin Z; Haraguchi G; Arai H; Mitaka C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jul; 26(7):478-9. PubMed ID: 25163104
[TBL] [Abstract][Full Text] [Related]
9. A Comparative Study of the Diagnostic and Prognostic Utility of Soluble Urokinase-type Plasminogen Activator Receptor and Procalcitonin in Patients with Sepsis and Systemic Inflammation Response Syndrome.
Sharma A; Ray S; Mamidipalli R; Kakar A; Chugh P; Jain R; Ghalaut MS; Choudhury S
Indian J Crit Care Med; 2020 Apr; 24(4):245-251. PubMed ID: 32565634
[TBL] [Abstract][Full Text] [Related]
10. Comparison of soluble urokinase plasminogen activator receptor, soluble triggering receptor expressed on myeloid cells 1, procalcitonin and C-reactive protein in distinguishing concurrent bacterial infection from idiopathic inflammatory myopathy.
Xiao Y; Luo H; Zhou B; Dai X; Huang J; Duan L; You Y; Zhang W; Zhao H; Xie Y; Zhou Y; Ning W; Li T; Liu S; Zhu H; Xie X; Jiang Y; Wu S; He W; Li Y
Rheumatol Int; 2017 Apr; 37(4):585-592. PubMed ID: 27878344
[TBL] [Abstract][Full Text] [Related]
11. Soluble urokinase plasminogen activator receptor predicts mortality in patients with systemic inflammatory response syndrome.
Raggam RB; Wagner J; Prüller F; Grisold A; Leitner E; Zollner-Schwetz I; Valentin T; Krause R; Hoenigl M
J Intern Med; 2014 Dec; 276(6):651-8. PubMed ID: 24645798
[TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein.
Pavcnik-Arnol M; Hojker S; Derganc M
Intensive Care Med; 2004 Jul; 30(7):1454-60. PubMed ID: 15127192
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of procalcitonin in patients with sepsis.
Mustafić S; Brkić S; Prnjavorac B; Sinanović A; Porobić Jahić H; Salkić S
Med Glas (Zenica); 2018 Aug; 15(2):93-100. PubMed ID: 30047536
[TBL] [Abstract][Full Text] [Related]
14. [The diagnostic value of different pro-inflammatory factor in early diagnosis of sepsis in patients with bloodstream infection].
Chen W; Zhao L; Niu S; Wang S; Sheng B; Zhen J; Gu X; Lyu C
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Mar; 26(3):165-70. PubMed ID: 24598289
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil CD64 combined with PCT, CRP and WBC improves the sensitivity for the early diagnosis of neonatal sepsis.
Yang AP; Liu J; Yue LH; Wang HQ; Yang WJ; Yang GH
Clin Chem Lab Med; 2016 Feb; 54(2):345-51. PubMed ID: 26351925
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin as a rapid diagnostic biomarker to differentiate between culture-negative bacterial sepsis and systemic inflammatory response syndrome: a prospective, observational, cohort study.
Anand D; Das S; Bhargava S; Srivastava LM; Garg A; Tyagi N; Taneja S; Ray S
J Crit Care; 2015 Feb; 30(1):218.e7-12. PubMed ID: 25263339
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic and prognostic significance of soluble urokinase plasminogen activator receptor in systemic inflammatory response syndrome.
Yilmaz G; Köksal I; Karahan SC; Mentese A
Clin Biochem; 2011 Oct; 44(14-15):1227-30. PubMed ID: 21816136
[TBL] [Abstract][Full Text] [Related]
18. Specific elevation of DcR3 in sera of sepsis patients and its potential role as a clinically important biomarker of sepsis.
Kim S; Mi L; Zhang L
Diagn Microbiol Infect Dis; 2012 Aug; 73(4):312-7. PubMed ID: 22647538
[TBL] [Abstract][Full Text] [Related]
19. Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards.
Ratzinger F; Haslacher H; Perkmann T; Schmetterer KG; Poeppl W; Mitteregger D; Dorffner G; Burgmann H
Eur J Clin Invest; 2015 Aug; 45(8):815-23. PubMed ID: 26046926
[TBL] [Abstract][Full Text] [Related]
20. Discriminative power of inflammatory markers for prediction of tumor necrosis factor-alpha and interleukin-6 in ICU patients with systemic inflammatory response syndrome (SIRS) or sepsis at arbitrary time points.
Oberhoffer M; Russwurm S; Bredle D; Chatzinicolaou K; Reinhart K
Intensive Care Med; 2000 Mar; 26 Suppl 2():S170-4. PubMed ID: 18470714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
